Reverse-payment patent settlements in the pharmaceutical industry: An analysis of U.S. antitrust law and EU competition law.
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 1, p. 153, doi. 10.1177/0003603X1405900107
- By:
- Publication type:
- Article
Works matching IS 0003603X AND DT 2014 AND VI 59 AND IP 1
Results: 7
1
2
Monopolization and abuse of dominance: Why Europe is different.
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 1, p. 129, doi. 10.1177/0003603X1405900106
- By:
- Publication type:
- Article
3
Economics in Merger Analysis.
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 1, p. 111, doi. 10.1177/0003603X1405900105
- By:
- Publication type:
- Article
4
Merger control procedures and institutions: A comparison of EU and U.S. practice.
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 1, p. 55, doi. 10.1177/0003603X1405900104
- By:
- Publication type:
- Article
5
Competition vs. financial stability in the aftermath of the crisis in the UK.
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 1, p. 31, doi. 10.1177/0003603X1405900103
- By:
- Publication type:
- Article
6
Competition policy and "too big" banks in the European Union and the United States.
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 1, p. 9, doi. 10.1177/0003603X1405900102
- By:
- Publication type:
- Article
7
Introduction: EU and U.S. competition enforcement--Convergence or divergence.
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 1, p. 1, doi. 10.1177/0003603X1405900101
- By:
- Publication type:
- Article